Ken Leslie

Ken Leslie has a diverse work experience spanning over two decades. Ken is currently working as the VP of Business Development at Prime Medicine, Inc. since March 2022. Prior to this, they held the position of Senior Director of Business Development - External Innovation at Vertex Pharmaceuticals from September 2018 to March 2022. Ken also worked as the Director of Strategy and Corporate Development at Pacira Pharmaceuticals, Inc. from August 2016 to September 2018. Ken started their career as a Research Technician at the Gene Therapy Core Facility at Cornell University Medical School in August 1999 and later served as a Senior Research Associate at the Memorial Sloan-Kettering Cancer Center from June 2001 to July 2008. From there, they transitioned to finance and worked as a Specialty Pharmaceuticals Equity Research Summer Research Associate at UBS Investment Bank in July 2009. Ken then held the role of Healthcare Analyst at Soros Fund Management from October 2009 to September 2012. Following this, they worked as an Analyst at Suffolk Capital Management from April 2013 to November 2014 before becoming a Healthcare Therapeutics Analyst at Goldwater Asset Management from November 2014 to April 2016. Ken Leslie's career trajectory showcases their expertise in research, strategy, corporate development, and business development within the pharmaceutical industry.

Ken Leslie obtained a BA degree in Molecular Biology, Neuroscience, and Pre-Med from an unspecified school, which they attended from 1995 to 1999. Subsequently, from 2008 to 2010, they pursued an MBA degree with a focus on Finance, although the specific institution is not mentioned.